As earnings season is upon us, we’re receiving a clearer view of what new medtech could be launching this year in the medical device space. Companies still feel hamstrung by macroeconomic pressures, supply chain issues and more. However, many pointed out that 2023 has plenty to look forward to. Several quarterly reports and earnings calls […]
BD
FDA authorizes BD’s combo COVID-flu-RSV test
BD (NYSE:BDX) announced today that it received FDA emergency use authorization (EUA) for a COVID-19, flu and RSV combination diagnostic. The company designed the molecular test to detect SARS-CoV-2, influenza A and B and respiratory syncytial virus (RSV). It’s used on the BD Max molecular diagnostic system. The test uses a single nasal or nasopharyngeal […]
5 reasons you should feel good about medtech companies in 2023
“Macroeconomic headwinds” is a phrase repeated a lot these days, but a string of positive medtech company earnings reports this week should cheer medical device industry insiders. The medical device industry may once again prove that it’s an economically resilient space. “While 2022 brought its share of supply chain and inflationary pressures, directionally, many companies […]
BD beats The Street in Q1, raises 2023 guidance
BD (NYSE:BDX) today posted first-quarter financial results that topped the consensus forecast and included increased full-year guidance. Shares of BDX were up slightly to $255.46 apiece in morning trading. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up more than 14%. The Franklin Lakes, New Jersey–based […]
How Embecta started strong and what’s ahead for the BD diabetes spinoff
Ten months after spinning off from BD, Embecta CEO Dev Kurdikar lays out what the future holds for the diabetes technology company. When Embecta became a standalone company in April 2022, CFO Jake Elguicze said he felt it was “uniquely positioned.” As a pure-play diabetes technology developer, its beginning phase hardly mirrors a normal startup. The former diabetes […]
How BD is getting more proactive about medtech cybersecurity
Medtech giant BD today detailed how it has taken proactive steps to ensure medtech cybersecurity in an increasingly critical environment. “Medical device cybersecurity has become more critical than ever as the number of smart, connected devices grows and healthcare expands into more care settings, including patient homes,” said Rob Suárez, the company’s chief information security […]
BD launches fully automated microbiology lab robotic track system
BD (NYSE:BDX) introduced its third-generation BD Kiestra total lab automation system. The next-gen BD Kietstra system includes a new robotic track system that automates lab specimen processing. The result helps reduce manual labor and wait time for results, the company said in a news release yesterday. Laboratories can create a custom and flexible total lab automation […]
BD, CerTest win FDA EUA for monkeypox diagnostic
BD (NYSE:BDX) and CerTest Biotec announced today that their monkeypox diagnostic received FDA emergency use authorization (EUA). The companies announced a partnership to develop the test in June. The Viasure monkeypox (Mpox) virus real-time PCR assay works with the BD Max system. The automated platform performs nucleic acid extraction and real-time PCR testing. It provides results for up […]
Michelle Quinn named acting general counsel for BD
BD (NYSE:BDX) announced today that it named Michelle Quinn as acting general counsel for the company. Quinn succeeds Samrat (Sam) Khichi in the role. Khichi informed the company of his intent to depart for a new opportunity, effective Feb. 3, 2023. Reporting to chair, president and CEO Tom Polen, Quinn holds responsibility for leading the […]
The biggest medtech stock gainers, losers in 2022
In another roller coaster year for medtech, these are the companies that saw their stock rise and fall the most drastically. The MassDevice MedTech 100 Index, which includes stocks of the world’s largest medical device companies, reflects the performance of many in the medtech space. In a tough year for a lot of businesses, the Index […]
The 10 biggest diabetes tech stories from 2022
2022 represented a landmark year for next-generation diabetes tech. Here are the biggest stories from the past year. Some companies picked up major regulatory nods. Others experienced major regulatory setbacks. Partnerships were formed and ended, while mergers and acquisitions came and went. There were many stories to choose from in the world of diabetes tech, […]